Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug ...

including a generic version of Symbicort and one other undisclosed inhalation product. Symbicort is an asthma and COPD medication with over $3 billion in annual sales, presenting a major market ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...

Flovent HFA, GSK’s brand name for its discontinued inhaler ... to cover a prescription for Symbicort as a Flovent replacement. In 2024, though, that drug was no longer included in the insurer ...